APA (7th ed.) Citation

Drick, N., Seeliger, B., Welte, T., Fuge, J., & Suhling, H. (2018). Anti-IL-5 therapy in patients with severe eosinophilic asthma – clinical efficacy and possible criteria for treatment response. BMC.

Chicago Style (17th ed.) Citation

Drick, Nora, Benjamin Seeliger, Tobias Welte, Jan Fuge, and Hendrik Suhling. Anti-IL-5 Therapy in Patients with Severe Eosinophilic Asthma – Clinical Efficacy and Possible Criteria for Treatment Response. BMC, 2018.

MLA (9th ed.) Citation

Drick, Nora, et al. Anti-IL-5 Therapy in Patients with Severe Eosinophilic Asthma – Clinical Efficacy and Possible Criteria for Treatment Response. BMC, 2018.